Trials / Completed
CompletedNCT02039557
Long Term Follow Up Protocol for NiCord®/CordIn™ (Omidubicel) Patients
Long Term Follow Up for Patients Who Have Received Allogeneic Stem Cell Transplantation of NiCord®/CordIn™, Umbilical Cord Blood-derived Ex Vivo Expanded Stem and Progenitor Cells
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 33 (actual)
- Sponsor
- Gamida Cell ltd · Industry
- Sex
- All
- Age
- 2 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This is an observational study that will monitor clinical outcomes of patients who have received a NiCord®/CordIn™ (omidubicel) transplant as part of a GC clinical interventional study and meet the eligibility criteria for this Long Term Follow Up study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | NiCord®/CordIn™ (omidubicel) |
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2023-06-29
- Completion
- 2023-06-29
- First posted
- 2014-01-17
- Last updated
- 2024-10-23
Locations
10 sites across 4 countries: United States, Netherlands, Singapore, Spain
Source: ClinicalTrials.gov record NCT02039557. Inclusion in this directory is not an endorsement.